The lymphoid-specific immunoglobulin heavy chain gene intron enhancer ( E) contains multiple binding sites for trans-acting nuclear factors. We have used a combination of in vitro and in vivo assays to reconstruct protein-DNA interactions on a minimal B cell-specific enhancer that contains three motifs, A, B, and E3. Using ETS-domain proteins that transactivate the minimal enhancer in non-lymphoid cells, we show that (i) PU.1 binds coordinately to both A and B sites in vitro and (ii) in the presence of Ets-1, this factor binds to the A site and PU.1 to the B site. Two factors, TFE3 and USF, bind to the E3 element. When the ETS proteins are present together with E3 binding proteins, a threeprotein-DNA complex is generated. Furthermore, we provide evidence for protein-protein interactions between Ets-1 and PU.1 proteins that bind to A and B sites, and between Ets-1 and TFE3 bound to the A and E3 sites. We propose that this domain of the enhancer is assembled into a nucleoprotein complex that contains two tissue-restricted ETS domain proteins that recognize DNA from the same side of the helix and one ubiquitously expressed bHLH-leucine zipper protein that binds between them, recognizing its site from a different side of the helix.
The immunoglobulinheavy chain (IgH) gene intron enhancer is a tissue-specific regulatory element that is necessary for expression of the IgH gene (1, 2). Since the proposal of Alt and colleagues of the correlation between transcription and immunoglobulin gene rearrangements (3-5), the enhancer has been considered a likely candidate to be the sequence that regulates rearrangements at this locus. Recently, this hypothesis has been directly verified in mice containing disrupted enhancer alleles (6, 7). Thus, the enhancer is activated at very early stages of B cell differentiation, prior to the onset of D H to J H rearrangements. In addition, experiments in transgenic mice have shown that this enhancer is sufficient to direct expression of heterologous genes in B and T lymphoid cells (8 -11).The enhancer contains binding sites for multiple DNA binding proteins, and tissue-specific activity has been proposed to be the consequence of both positive and negative regulatory proteins. Positive regulation is effected by lymphoid-specific transcription activators, such as those that bind to the A, B (12-15), and octamer elements (16 -18). Negative regulation is effected by proteins found in non-lymphoid cells that may suppress enhancer activity (19 -22), such as those that bind to the E5 site within the enhancer (23, 24). In addition, there are several sites within the enhancer referred to as E motifs. These elements, E1-E5, fit the consensus CANNTG and bind proteins belonging to the basic helix-loop-helix family of transcription factors (25) that are expressed in both lymphoid and nonlymphoid cells. We have previously shown that mutation of either A or B elements abrogates B cell-specific activity of a 170 nucleotide enhancer ( 170) that contains both these elements as well as E1, E3, and E5. Mutati...